Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.
Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 23:01:35 GMT 2025
by
admin
on
Mon Mar 31 23:01:35 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
7V9926378A
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
36789
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
||
|
WHO-ATC |
V09IB02
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m9791
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1743091
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
C1469
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
300000055499
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
138955-27-8
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
SATUMOMAB PENDETIDE
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
7V9926378A
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY | |||
|
DB00057
Created by
admin on Mon Mar 31 23:01:35 GMT 2025 , Edited by admin on Mon Mar 31 23:01:35 GMT 2025
|
PRIMARY |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_286 |
| N | 2_286 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY | |||
|
|
ACTIVE MOIETY |
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| CHELATING AGENT | CONJUGATION |
|
SODIUM METAPERIODATE | 98W4A29X43 | |
| OXIDIZES SUGAR | OXIDIZER |
|
SODIUM METAPERIODATE | 98W4A29X43 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| MOIETY | SUGAR |
Amount:
|
INDIUM CATION IN-111 | WJZ06C0H8L |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|